2020年美国内分泌协会《临床实践指南:内分泌疾病患者的血脂管理》解读  

Interpretation of Lipid Management in Patients with Endocrine Disorders:an Endocrine Society Clinical Practice Guideline Issued by The Endocrine Society in 2020

作　　者：邓臣前 陈树春[2] DENG Chenqian;CHEN Shuchun(Graduate School,Hebei North University,Zhangjiakou 075000,China;Hebei General Hospital,Shijiazhuang 050051,China)

机构地区：[1]河北北方学院研究生学院,河北省张家口市075000 [2]河北省人民医院,河北省石家庄市050051

出　　处：《中国全科医学》2021年第21期2646-2654,共9页Chinese General Practice

摘　　要：近年来,包括中国在内的多个国家相继发布了内分泌疾病患者血脂管理相关指南,体现出血脂管理是内分泌疾病患者治疗中一个相当重要的“版块”,但多数指南只是针对单一内分泌疾病,并没有针对内分泌疾病患者血脂异常进行综合阐述。2020年美国内分泌协会发布的《临床实践指南:内分泌疾病患者的血脂管理》首次针对内分泌疾病患者血脂异常进行了详细阐述,对我国内分泌疾病合并血脂异常患者的管理具有重要指导意义,本文对该指南主要内容进行了解读。In recent years,China and many other countries have issued guidelines on lipid management for endocrine disease patients,indicating that lipid management is a very important section in endocrine disease treatment.However,most of previous guidelines only focused on managing lipids in patients with only one endocrine disease,with no systematic elaboration of lipid management in patients with multiple endocrine diseases.The Lipid Management in Patients with Endocrine Disorders:an Endocrine Society Clinical Practice Guideline issued by The Endocrine Society in 2020,is a guideline detailedly elaborates lipid management in patients with endocrine diseases for the first time,which will significantly contribute to lipid management in Chinese patients with endocrine diseases.For this reason,we interpreted the main points of this guideline.

关 键 词：内分泌系统疾病 血脂异常 心血管疾病 动脉粥样硬化 指南 高甘油三酯血症 糖尿病 肥胖管理 甲状腺疾病 库欣综合征 生长激素 多囊卵巢综合征 激素类 

分 类 号：R725.8[医药卫生—儿科]